Document is current
Any future updates will be listed below
-
Authors
Zhang, Fengwen http://orcid.org/0000-0001-7427-3771
Jenkins, Jesse
de Carvalho, Renan V. H.
Nakandakari-Higa, Sandra
Chen, Teresia http://orcid.org/0000-0002-5606-9803
Abernathy, Morgan E.
Baharani, Viren A.
Nyakatura, Elisabeth K.
Andrew, David
Lebedeva, Irina V. http://orcid.org/0000-0002-1693-9392
Lorenz, Ivo C. http://orcid.org/0000-0002-7373-1176
Hoffmann, H.-Heinrich
Rice, Charles M. http://orcid.org/0000-0003-3087-8079
Victora, Gabriel D.
Barnes, Christopher O. http://orcid.org/0000-0003-2754-5951
Hatziioannou, Theodora http://orcid.org/0000-0002-7889-0766
Bieniasz, Paul D. http://orcid.org/0000-0002-2368-3719
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (P01 AI165075, R37AI64001, P01 AI165075, R01 78788, P01 AI165075)
Howard Hughes Medical Institute (-, -)
- License Information
-
More Information
Article History
Received: 29 September 2022
Accepted: 19 April 2023
First Online: 15 May 2023
Competing interests
: The Rockefeller University has filed a patent application for anti-hACE2 antibodies on which F.Z., T.H. and P.D.B. are listed as inventors. The other authors have no competing interests.
